AAO research
The AAO accepted major research contributions and scholarly authorship, but rejected awards, membership, media, judging, and leadership evidence.
Decision snapshot
Decision detail | Source-backed value |
|---|---|
Decision ID | Apr302008_01B2203 |
Disposition stated in the source | The appeal was dismissed after two criteria were accepted and final merits did not establish sustained acclaim or top-of-field standing. |
Source location |
A pending patent and research grants were not awards
The petitioner relied on a patent application and research grants. The AAO found that filing a patent and receiving research funding did not constitute receipt of nationally or internationally recognized prizes or awards for excellence.
Source: Apr302008_01B2203 page 3.
Membership and media claims failed on their evidence
The record showed a paid application for European Society of Gene Therapy membership, not proof of admission or achievement-based selection. A magazine article discussed another researcher’s study and mentioned the petitioner only in passing; papers citing her work were primarily about their own authors and did not evaluate her standing. The AAO rejected both criteria.
Source: Apr302008_01B2203 page 4; Apr302008_01B2203 page 5.
Routine review and supervisory duties did not establish judging
Letters described manuscript-review activity, but the record lacked editorial correspondence, completed evaluations, or identification of the work reviewed. The AAO also found review and supervision inherent to the petitioner’s positions, and her Experimental Animal Core manager appointment postdated filing. It did not count these duties as qualifying judging.
Source: Apr302008_01B2203 page 6; Apr302008_01B2203 page 7.
Research impact and article authorship were accepted, but the threshold was not met
Letters and research evidence persuaded the AAO that the petitioner’s work had major significance in gene therapy; it also accepted her authorship in major scientific journals and noted at least 141 citations. However, leading or critical role was not established: the record did not show the Gene Transfer Facility’s distinguished reputation or that her role was critical to the institution. The final discussion found no sustained acclaim or top-of-field standing and dismissed the appeal.
Source: Apr302008_01B2203 page 8; Apr302008_01B2203 page 9; Apr302008_01B2203 page 10; Apr302008_01B2203 page 11; Apr302008_01B2203 page 12.
Current framework and related reading
EB-1A Original Contributions: Evidence of Major Significance
EB-1A Scholarly Articles: Authorship, Publication, and Citations
EB-1A Initial Evidence: Three of Ten Criteria and the Award Route
The decisions above are non-precedent assessments of particular records. Historical reasoning is identified as historical; consult current guidance for the present framework.